New Triple Myeloma Treatment Cuts Cancer Return by 52%

A groundbreaking combination therapy for relapsed multiple myeloma has shown remarkable results, cutting the risk of cancer progression in half.

This new treatment option brings fresh hope to patients facing one of blood cancer's toughest challenges.